Sign in
4

Changes in Ownership

HALOZYME THERAPEUTICS, INC. Filed Acc 0001179110-20-010606

SVP, Chief Technical Officer sold 12,000 shares at $30.43 ($365,148)

From the SEC's structured data for this filing

Trades in this filing

LaBarre Michael J. · SVP, Chief Technical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-10-20 Sale : show line 1 in the form −12,000 $30.43 $365,148 146,800 D
Open-market sales · 12,000 sh · avg $30.43 · $365,148
Loading xslF345X03/edgar.xml…